LinkedIn Profile

Access KinoDyn historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Sector Industry
private:kinodyn 5040591 May 29th, 2019 12:00AM KinoDyn, Inc. 25 0.00 Open Biotechnology May 29th, 2019 08:59AM May 29th, 2019 08:59AM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma. Open Open
private:kinodyn 5040591 Mar 19th, 2018 12:00AM KinoDyn, Inc. 22 0.00 Open Biotechnology Mar 18th, 2018 11:01PM Mar 18th, 2018 11:01PM Open
private:kinodyn 5040591 Feb 17th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.
private:kinodyn 5040591 Feb 16th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.
private:kinodyn 5040591 Feb 15th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.
private:kinodyn 5040591 Feb 14th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.
private:kinodyn 5040591 Feb 13th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.
private:kinodyn 5040591 Feb 12th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.
private:kinodyn 5040591 Feb 11th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.
private:kinodyn 5040591 Feb 10th, 2018 12:00AM KinoDyn, Inc. 21 0.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind’ approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.